Rocket


Overview
Financials
News + Filings





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Soul Biotechnology Corp

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18
   10-K10-K10-K10-K/A10-K/A
Revenues:  
    One Major Customer      0.0
    Other      0.0
Revenues  0.30.00.00.00.0
            Revenue growth  366069.1%-63.5%-98.8%51.8% 
Cost of goods sold  0.10.00.00.00.0
Gross profit  0.20.00.00.00.0
            Gross margin  76.1%100.0%83.8%67.1%62.6%
Selling, general and administrative   [+]0.50.00.00.00.0
Research and development      0.0
Other operating expenses  0.0    
EBITDA   [+]-0.3    
            EBITDA margin  -87.4%-56566.7%-19339.6%-127.1%-324.8%
Depreciation  0.0    
EBITA  -0.30.00.00.00.0
            EBITA margin  -101.2%-56566.7%-19339.6%-127.1%-324.8%
Amortization of intangibles  0.0    
EBIT   [+]-0.30.00.00.00.0
            EBIT margin  -114.9%-56566.7%-19339.6%-127.1%-324.8%
Non-recurring items   [+]  0.0  
Interest expense, net   [+]0.00.00.00.00.0
Pre-tax income  -0.30.0-0.10.00.0
Income taxes  0.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%
Net income  -0.30.0-0.10.00.0
            Net margin  -115.5%-56540.7%-29114.4%-126.3%-323.9%
   
Basic EPS   [+]$0.00$0.00$0.00$0.00$0.00
Diluted EPS   [+]$0.00$0.00$0.00$0.00$0.00
   
Shares outstanding (basic)   [+]69.323.923.923.821.5
Shares outstanding (diluted)   [+]69.323.923.923.821.5
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy